PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
20-Jul-2020 Phlexglobal and Arkivum join forces to enable Trial Master File data compliance over its entire extended lifecycle Arkivum
20-Jul-2020 Campaigners warn that the government is racing ahead with vaccine nationalism Pfizer
20-Jul-2020 Acumentice expands senior team with Purdy appointment Acumentice
20-Jul-2020 Polyplus-transfection launches a residual test for its transfection reagent products for ATMP sector Polyplus-transfection
20-Jul-2020 Annual Review 2020 highlights impact on growth and productivity in the UK cell and gene therapy industry Cell and Gene Therapy Catapult
20-Jul-2020 AMRYT TO ANNOUNCE Q2 RESULTS ON AUGUST 6, 2020 Amryt
20-Jul-2020 BERGENBIO ANNOUNCES FIRST PATIENT DOSED IN RECURRENT GLIOBLASTOMA INVESTIGATOR SPONSORED PHASE I/II STUDY ASSESSING SELECTIVE AXL INHIBITOR BEMCENTINIB BerGenBio ASA
20-Jul-2020 Santhera to Join SIX Swiss Exchange Life Science Industry Indices Santhera Pharmaceuticals
20-Jul-2020 Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2 BioNTech
17-Jul-2020 Verona Pharma Raises $200 Million in Oversubscribed Private Placement and Subscription Verona Pharma plc
17-Jul-2020 MARINOMED BIOTECH AG: CARRAGELOSE® EFFECTIVE AGAINST SARS-CoV-2 IN CELL CULTURE ASSAYS Marinomed Biotech AG
17-Jul-2020 Farxiga granted Fast Track Designation in the US for heart failure following acute myocardial infarction leveraging an innovative registry-based trial design AstraZeneca
17-Jul-2020 PureTech Founded Entity Vor Biopharma Appoints Daniella Beckman to its Board of Directors PureTech Health plc
17-Jul-2020 RedHill Biopharma Receives Approval for Phase 2/3 COVID-19 Study in Russia RedHill Biopharma Ltd
17-Jul-2020 Genmab Announces Net Sales of DARZALEX® for the Second Quarter of 2020 Genmab
17-Jul-2020 Celltrion launches human clinical trial of potential COVID-19 antiviral antibody treatment following positive pre-clinical results Celltrion Healthcare
17-Jul-2020 ASLAN PHARMACEUTICALS ANNOUNCES THE MOVE OF ITS PRIMARY LISTING TO NASDAQ AND DELISTING FROM TAIPEI EXCHANGE ASLAN Pharmaceuticals
17-Jul-2020 SurePulse lands £1m investment to expand its share of neonatal healthtech market SurePulse Medical Ltd
17-Jul-2020 Eli Lilly’s and Regeneron’s COVID-19 mAbs spark interest as monotherapies along with potential as cocktails for treatment and postexposure prevention, says GlobalData GlobalData
17-Jul-2020 Idorsia establishes US commercial operations and leadership team Idorsia Ltd